跳至主要内容
临床试验/NL-OMON32894
NL-OMON32894尚未招募不适用

Selective Pulmonary Artery Perfusion with carboplatin for the treatment of NSCLC: a phase I trial - Selective Pulmonary Artery Perfusion

cardioth chir0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Stage c3a en c3b NSCLC

排除标准

  • Other stages of NSCLC, age under 18 years old (however, NSCLC has never been described during childhood), patients who are mentally not able to chose whether to be involved in the study or not, pregnancy or lactation, severe comorbidity, uncontrollable infectious disease, Liver/kidney insufficiency; serum creatinine more than 130 µmol/l and urine creatinine clearance less than 60 ml/min, ALAT and ASAT more than 3 times normal

研究者

发起方
cardioth chir

相似试验